DC
RNAM

Diametric Capital’s Avidity Biosciences RNAM Stock Holding History

Diametric Capital’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,000
Closed -$721K – 565
2025
Q4 		$721K Buy
+10,000
New +$646K 0.19% 134

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Diametric Capital's RNAM Position: Q1 2026 in Review

Diametric Capital sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 10,000 shares — an estimated $721K sold.

Diametric Capital first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $721K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Diametric Capital reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Diametric Capital sold 10,000 Avidity Biosciences shares in Q1 2026, an estimated $721K.
  • Diametric Capital first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Diametric Capital's Avidity Biosciences position peaked at $721K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Diametric Capital's 13F filing for Q1 2026, filed 15 May 2026.